Posttherapeutic 131I SPECT-CT offers high diagnostic accuracy when the findings on conventional planar imaging are inconclusive and allows a tailored patient treatment regimen

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 36, Issue 6, 2009, Pages 886-893

  Kohlfuerst, S ^a   Igerc, I ^a   Lobnig, M ^a   Gallowitsch, H J ^a   Gomez Segovia, I ^a   Matschnig, S ^a   Mayr, J ^a   Mikosch, P ^a   Beheshti, M ^b   Lind, P ^a  

^a GENERAL HOSPITAL KLAGENFURT   (Austria)

^b St Vincent's Hospital   (Austria)

Author keywords

Dual imaging modality; Posttherapeutic scintigraphy; Radioiodine; SPECT CT; Thyroid cancer

Indexed keywords

IODINE 131;

ADULT; AGED; ARTICLE; BONE METASTASIS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DRUG MEGADOSE; DRUG UPTAKE; FEMALE; HUMAN; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; PATIENT CARE PLANNING; RADIOISOTOPE THERAPY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THYROID CANCER; WHOLE BODY SCINTISCANNING;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; NECK; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; THYROID NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED; UNCERTAINTY; WHOLE BODY IMAGING;

EID: 65649112430     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-008-1044-2     Document Type: Article

References (31)

1. F Pacini M Schlumberger H Dralle R Elisei JWA Smit W Wiersinga European Thyroid Cancer Taskforce 2006 European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium Eur J Endocrinol 154 787 803
2. V Fatourechi ID Hay BP Mullan GA Wiseman GZ Eghbali-Fatourechi LM Thorson 2000 Are posttherapy radioiodine scans informative and do they influence subsequent therapy of patients with differentiated thyroid cancer? Thyroid 10 573 577
3. M Schlumberger G Berg O Cohen L Duntas F Jamar B Jarzab 2004 Follow-up of low risk patients with differentiated thyroid carcinoma: a European perspective Eur J Endocrinol 150 105 112
4. M Schlumberger F Pacini WM Wiersinga A Toft JW Smit FS Franco 2004 Follow-up and management of differentiated thyroid carcinoma: a European perspective in clinical practice Eur J Endocrinol 151 539 548
5. WG Spies CH Wojtowicz SM Spies AY Shah AM Zimmer 1989 Value of post-therapy whole-body imaging in the evaluation of patients with thyroid carcinoma having undergone high-dose I-131 therapy Clin Nucl Med 14 793 800
6. RR Cavalieri 1996 Nuclear imaging in the management of thyroid carcinoma Thyroid 6 485 492
7. SI Sherman ET Tielens S Sostre MD Wharam Jr PW Ladenson 1994 Clinical utility of posttreatment radioiodine scans in the management of patients with thyroid carcinoma J Clin Endocrinol Metab 78 629 634
8. F Pacini M Schlumberger C Harmer GG Berg O Cohen L Duntas 2005 Post-surgical use of radioiodine (131 I) in patients with papillary and follicular thyroid cancer and the issue of remnant ablation: a consensus report Eur J Endocrinol 153 651 659
9. P Lind S Kohlfürst 2006 Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer Semin Nucl Med 36 194 205
10. B Shapiro V Rufini A Jarwan 2000 Artifacts, anatomical and physiological variants, and unrelated diseases that might cause false-positive whole-body 131 I scans in patients with thyroid cancer Semin Nucl Med 30 115 132
11. SM Bakheet MM Hammami 1994 False positive radioiodine whole-body scan in thyroid cancer patients due to unrelated pathology Clin Nucl Med 19 325 329
12. J Andreas K Bruhl D Eissner 1997 False-positive I-131 whole-body imaging after I-131 therapy for a follicular carcinoma Clin Nucl Med 22 123 124
13. SI Sherman ET Tielens S Sostre MD Wharam Jr PW Ladenson 1994 Clinical utility of posttreatment radioiodine scans in the management of patients with thyroid carcinoma J Clin Endocrinol Metab 78 629 634
14. T Leitha A Staudenherz 2003 Frequency of diagnostic dilemmas in 131 I whole body scanning Nuklearmedizin 42 55 62
15. Y Yamamoto Y Nishiyama T Monden Y Matsumura K Satoh M Ohkawa 2003 Clinical usefulness of fusion of 131I SPECT and CT images in patients with differentiated thyroid carcinoma J Nucl Med 44 1905 1910
16. Y Krausz M Klein B Uziely 2004 Impact of SPECT/CT on assessment of 131 I-avid sites in differentiated thyroid cancer J Nucl Med 45 349
17. J Ruf L Lehmkuhl H Bertram D Sandrock H Amthauer B Humplik 2004 Impact of SPECT and integrated low-dose CT after radioiodine therapy on the management of patients with thyroid carcinoma Nucl Med Commun 25 1177 1182
18. K Tharp O Israel J Hausmann L Bettman WH Martin M Daitzchman 2004 Impact of 131I-SPECT/CT images obtained with an integrated system in the follow-up of patients with thyroid carcinoma Eur J Nucl Med Mol Imaging 31 1435 1442
19. Y Krausz O Israel 2006 Single-photon emission computed tomography/computed tomography in endocrinology Semin Nucl Med 36 267 274
20. SC Cherng YF Wang YM Fan CY Chen YN Yuan CY Cheng 2005 Malignant struma ovarii with peritoneal implants and pelvic structures and liver metastases demonstrated by I-131 SPECT and low-dose CT Clin Nucl Med 30 797 798
21. C von Falck G Beer KF Gratz M Galanski 2007 Renal metastases from follicular thyroid cancer on SPECT/CT Clin Nucl Med 32 751 752
22. H Sakahara S Yamashita K Suzuki M Imai T Kosugi 2007 Visualization of nasolacrimal drainage system after radioiodine therapy in patients with thyroid cancer Ann Nucl Med 21 525 527
23. N Aide E Lehembre R Gervais S Bardet 2007 Unusual intratracheal metastasis of differentiated thyroid cancer accurately depicted by SPECT/CT acquisition after radioiodine ablation Thyroid 17 1305 1306
24. EL Mazzaferri SM Jiang 1994 Long term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer Am J Med 49 418 428
25. ID Hay EJ Bergstralh JR Goellner JR Ebersold CS Grant 1993 Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at an institution during 1940 through 1989 Surgery 114 1050 1057
26. ID Hay GB Thompson CS Grant EJ Bergstralh CE Dvorak CA Gorman 2002 Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1990): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients World J Surg 8 879 885
27. DP Byar SB Green P Dor ED Williams J Colon HA van Gilse 1979 A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. Thyroid Cancer Cooperative Group Eur J Cancer 15 1033 1041
28. J Tenvall A Biorklund T Moller J Ranstam M Akerman 1986 Is the EORTC prognostic index of thyroid cancer valid in differentiated thyroid carcinoma? Retrospective multivariate analysis of differentiated thyroid carcinoma with long follow-up Cancer 57 1405 1414
29. AR Shaha TR Loree JP Shah 1995 Prognostic factors and risk group analysis in follicular carcinoma of the thyroid Surgery 118 1131 1136
30. SI Sherman JD Brierly M Sperling KB Ain ST Bigos DS Cooper 1998 Prospective multicenter study of thyroid cancer treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Study Registry Group Cancer 83 1012 1021
31. TP Links KM van Tol PL Jager JT Plukker DA Piers HM Boezen 2005 Life expectancy in differentiated thyroid cancer: a novel approach to survival analysis Endocr Relat Cancer 12 273 280